MM-398

​With pending drug approval, Merrimack Pharma set to be area's next commercial biotech
Bizjournals.com
Tue, 09/8/15 - 02:02 pm
Merrimack Pharmaceuticals
MM-398
FDA
U.S. FDA Grants Priority Review for MM-398 New Drug Application
Yahoo
Thu, 06/25/15 - 08:59 am
FDA
MM-398
Merrimack Pharmaceuticals
metastatic pancreatic cancer
Merrimack Pharmaceuticals and Baxter BioScience Announce Completion of New Drug Application Submission to U.S. FDA for MM-398 as a Treatment for Post-Gemcitabine Metastatic Pancreatic Cancer
Yahoo
Mon, 04/27/15 - 09:44 am
Merrimack Pharmaceuticals
Baxter International
MM-398
metastatic pancreatic cancer
Merrimack Does Well to License Marginal Cancer Drug to Baxter
TheStreet.com
Wed, 09/24/14 - 08:30 am
Merrimack Pharmaceuticals
MM-398
pancreatic cancer
Baxter International
4 Biotech Stocks Worth A Look Ahead Of FDA Approvals
Yahoo/Benzinga
Thu, 07/3/14 - 12:07 pm
FDA
drug approvals
Acadia
Alexion
InterMune
Merrimack Pharmaceuticals
Soliris
pimavanserin
MM-398
Esbriet
The Path to FDA Approval Could Launch Seven Biotech Stocks Much Higher
24/7 Wall St
Wed, 07/2/14 - 11:49 am
Alexion
InterMune
FDA
Acadia
Kythera
Intercept Pharmaceuticals
Merrimack Pharmaceuticals
Relypsa
MM-398
patiromer
Esbriet
ATX-101
Soliris
Flint
pimavanserin
Three Companies That Want to Cure Pancreatic Cancer
Yahoo/247WallStreet
Thu, 05/22/14 - 10:10 am
pancreatic cancer
Celgene
Abraxane
Incyte
ruxolitinib
Merrimack Pharmaceuticals
MM-398
Merrimack Pharmaceuticals: Setting The Record Straight On MM 398
Seeking Alpha
Fri, 05/16/14 - 03:46 pm
Merrimack Pharmaceuticals
MM-398
metastatic pancreatic cancer
Is Merrimack Pharmaceuticals Worth More Than $700 Million?
Motley Fool
Mon, 05/5/14 - 05:02 pm
Merrimack Pharmaceuticals
pancreatic cancer
MM-398
Gemzar
Eli Lilly
Celgene
Abraxane
Merrimack cancer drug combination improves survival in study
Yahoo/Reuters
Thu, 05/1/14 - 08:27 am
Merrimack Pharmaceuticals
metastatic pancreatic cancer
MM-398
2 Biotech Stocks to Watch: Merrimack Pharmaceuticals and Sunesis Pharmaceuticals
Motley Fool
Thu, 04/10/14 - 11:13 pm
Merrimack Pharmaceuticals
Sunesis
pancreatic cancer
MM-398
vosaroxin
3 Small Cap Biotechs Developing Novel Cancer Treatments
Motley Fool
Wed, 02/19/14 - 12:56 pm
Inovio
VGX-3100
Cervical Intraepithelial Neoplasia
MM-398
Merrimack Pharmaceuticals
acute myeloid leukemia
vosaroxin
Sunesis
2014 Could Be A Big Year For Inovio, Merrimack, And NeoStem
Seeking Alpha
Wed, 12/4/13 - 09:24 am
Inovio
Merrimack Pharmaceuticals
NeoStem
VGX-3100
MM-398
AMR-001
Merrimack Progresses With MM-398
Yahoo/Zacks
Fri, 08/30/13 - 08:45 am
Merrimack Pharmaceuticals
MM-398
pancreatic cancer
Merrimack Study Data Published
Yahoo/Zacks
Sat, 08/24/13 - 11:36 am
Merrimack Pharmaceuticals
MM-398
pancreatic cancer
Biotech Stock Mailbag: 2013 Clinical Trials Calendar
TheStreet.com
Fri, 06/7/13 - 08:41 am
Zerenex
Xoma
Vical
Takeda
sovaprevir
Soluble Ferric Pyrophosphate
Rockwell Medical
Orexigen
MM-398
Merrimack Pharmaceuticals
MannKind
Keryx
GTx
GSK
gevokizumab
enobosarm
Coronado Biosciences
Contrave
CNDO-201
clinical trials
ChemoCentryx
CCX140
Biodel
BIOD-123
Amigal
Amicus Therapeutics
Alnylam
ALN-TTR02
Allovectin
Afrezza
Achillion
ACH-3102
3 Events Biotech Investors Need to Watch in 2013
Motley Fool
Thu, 02/14/13 - 10:28 am
Vical
Allovectin
metastatic melanoma
Merrimack Pharmaceuticals
MM-398
pancreatic cancer
Afrezza
diabetes
MannKind
3 Things to Watch at Merrimack
Motley Fool
Sun, 12/30/12 - 12:12 pm
Merrimack Pharmaceuticals
MM-398
pancreatic cancer
MM-121
breast cancer
lung cancer
Does Merrimack Pharmaceuticals Have A Blockbuster Drug With MM-398?
Seeking Alpha
Thu, 12/6/12 - 05:32 pm
Merrimack Pharmaceuticals
MM-398
pancreatic cancer
5 promising pancreatic cancer drugs
Fierce Biotech
Thu, 10/13/11 - 01:23 pm
Amgen
Takeda
Ganitumab
KAEL-GemVax
GV1001
HyperAcute Pancreas
NewLink Genetics
GI-4000
GlobeImmune
MM-398
Merrimack Pharmaceuticals
pancreatic cancer